Single-atom fluorescence switch: a general approach toward visible-light-activated dyes for biological imaging J Tang, MA Robichaux, KL Wu, J Pei, NT Nguyen, Y Zhou, TG Wensel, ... Journal of the American Chemical Society 141 (37), 14699-14706, 2019 | 115 | 2019 |
Mitochondrial metabolism as a target for acute myeloid leukemia treatment SB Panina, J Pei, NV Kirienko Cancer & Metabolism 9 (1), 17, 2021 | 44 | 2021 |
Utilizing synergistic potential of mitochondria-targeting drugs for leukemia therapy SB Panina, J Pei, N Baran, M Konopleva, NV Kirienko Frontiers in oncology 10, 435, 2020 | 33 | 2020 |
Addition of isocyanide-containing amino acids to the genetic code for protein labeling and activation Y Chen, KL Wu, J Tang, A Loredo, J Clements, J Pei, Z Peng, R Gupta, ... ACS chemical biology 14 (12), 2793-2799, 2019 | 30 | 2019 |
Mitochondria-affecting small molecules ameliorate proteostasis defects associated with neurodegenerative diseases E Tjahjono, J Pei, AV Revtovich, TJE Liu, A Swadi, MC Hancu, JG Tolar, ... Scientific reports 11 (1), 17733, 2021 | 15 | 2021 |
Epichaperome inhibition targets TP53-mutant AML and AML stem/progenitor cells BZ Carter, PY Mak, M Muftuoglu, W Tao, B Ke, J Pei, AD Bedoy, ... Blood 142 (12), 1056-1070, 2023 | 6 | 2023 |
Novel mitochondria-targeting compounds selectively kill human leukemia cells SB Panina, J Pei, N Baran, E Tjahjono, S Patel, G Alatrash, S Konoplev, ... Leukemia 36 (8), 2009-2021, 2022 | 4 | 2022 |
An automated differential nuclear staining assay for accurate determination of mitocan cytotoxicity J Pei, SB Panina, NV Kirienko JoVE (Journal of Visualized Experiments), e61295, 2020 | 4 | 2020 |
Epichaperome Inhibition Targets Kinase and TP53 Mutant Therapy Resistant AML BZ Carter, PY Mak, W Tao, LB Ostermann, Y Nishida, N Pemmaraju, ... Blood 140 (Supplement 1), 5930-5931, 2022 | | 2022 |
Small Molecule Stabilization of PINK-1/PINK1 Improves Neurodegenerative Disease E Tjahjono, J Pei, AV Revtovich, TJE Liu, A Swadi, NV Kirienko bioRxiv, 2021.06. 07.447442, 2021 | | 2021 |
Targeting Mitochondria Metabolisms for Novel AML Therapy Development J Pei Rice University, 2021 | | 2021 |